Ventyx Biosciences, Inc. Common Stock earnings per share and revenue
On 06 de nov. de 2025, VTYX reported earnings of -0.32 USD per share (EPS) for Q3 25, beating the estimate of -0.45 USD, resulting in a 30.09% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -5.29% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 10 analistas forecast an EPS of -0.37 USD, with revenue projected to reach -- USD, implying an aumentar of 15.63% EPS, and aumentar of 0.00% in Revenue from the last quarter.
FAQ
What were Ventyx Biosciences, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Ventyx Biosciences, Inc. Common Stock reported EPS of -$0.32, beating estimates by 30.09%, and revenue of $0.00, 0% as expectations.
How did the market react to Ventyx Biosciences, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -5.29%, changed from $9.26 before the earnings release to $8.77 the day after.
When is Ventyx Biosciences, Inc. Common Stock expected to report next?
The next earning report is scheduled for 04 de fev. de 2026.
What are the forecasts for Ventyx Biosciences, Inc. Common Stock's next earnings report?
Based on 10
analistas, Ventyx Biosciences, Inc. Common Stock is expected to report EPS of -$0.37 and revenue of -- for Q4 2025.